AgeX Therapeutics, Inc.

AMEX:AGE

0.4302 (USD) • At close November 17, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 0.0050.0560.0460.0090.010.0080.0090.0120.0050.0270.0240.0370.0560.5050.4340.4140.5150.5490.4110.380.3880.3130.380.4640.239
Kosten van de omzet 00.0340.0330.0050.0010.0010.0050.0060.0010.0010.0020.0130.0030.0380.050.0360.0340.0790.0490.0530.0630.180.0780.0790.109
Brutowinst 0.0050.0220.0130.0040.0090.0070.0040.0060.0040.0260.0220.0240.0530.4670.3840.3780.4810.470.3620.3270.3250.1330.3020.3850.13
Brutowinstmarge 10.3930.2830.4440.90.8750.4440.50.80.9630.9170.6490.9460.9250.8850.9130.9340.8560.8810.8610.8380.4251.0110.830.544
Onderzoek- en ontwikkelingskosten 1.1060.1490.2180.160.1740.2080.1620.2590.3960.3760.2750.4810.3241.1860.8391.351.6031.4691.4471.651.3381.5231.3321.3842.391
Algemene en administratieve kosten 1.223.4332.1721.731.9931.5811.3921.3381.661.5171.4211.7482.0221.7281.9491.6532.0731.7172.1942.1192.1091.9681.2541.1351.29
Verkoop- en marketingkosten 0000000000000000000000000
Verkoop-, algemene en administratieve kosten 1.223.4332.1721.731.9931.5811.3921.3381.661.5171.4211.7482.0221.7281.9491.6532.0731.7172.1942.1192.1091.9681.2541.1351.29
Overige kosten 00.0010.0030.0040.0030.0040.0020.004-0.0840.0030.0040.0040.4370.05-0.012-0.0190.0250.0170.0480.257-0.0280.052-0.0220.156-0.003
Bedrijfskosten 2.3263.5822.3691.892.1671.7891.5541.5972.0561.8931.6962.2292.3462.9142.7883.0033.6763.1863.6413.7693.4473.4912.5862.5193.681
Bedrijfsresultaat -2.321-3.56-2.356-1.886-2.158-1.782-1.55-1.591-2.052-1.867-1.674-2.205-2.293-2.447-2.404-2.625-3.195-2.716-3.279-3.442-3.122-3.358-2.202-2.134-3.551
Bedrijfsresultaat ratio -464.2-63.571-51.217-209.556-215.8-222.75-172.222-132.583-410.4-69.148-69.75-59.595-40.946-4.846-5.539-6.341-6.204-4.947-7.978-9.058-8.046-10.728-5.795-4.599-14.858
Totaal overige inkomsten en kosten netto -7.1160.1020.003-0.001-1.127-0.979-0.886-1.027-0.6550.0030.0040.0040.5430.05-0.012-0.0190.0250.0170.0480.257-0.0280.052-0.0220.1563.212
Inkomen voor belasting -9.437-3.458-5.389-2.679-3.285-2.761-2.436-2.618-2.707-2.159-1.955-2.475-1.993-2.608-2.565-2.731-3.222-2.723-3.223-3.152-3.138-3.274-2.185-1.951-0.321
Inkomen voor belasting ratio -1,887.4-61.75-117.152-297.667-328.5-345.125-270.667-218.167-541.4-79.963-81.458-66.892-35.589-5.164-5.91-6.597-6.256-4.96-7.842-8.295-8.088-10.46-5.75-4.205-1.343
Belastingkosten 0-0.0023.0510.7862.219-0.0570.8851.0270.654-0.010.2890.2770.232-0.15-0.022-0.042-0.0350.0180.0540.0030.0730.141-0.073-0.048-0.104
Nettowinst -9.437-3.456-5.401-2.669-5.504-2.704-3.321-3.645-3.361-2.158-1.955-2.474-2.088-2.446-2.543-2.689-3.187-2.711-3.221-3.089-3.133-3.186-2.151-1.93-0.235
Nettowinstmarge -1,887.4-61.714-117.413-296.556-550.4-338-369-303.75-672.2-79.926-81.458-66.865-37.286-4.844-5.859-6.495-6.188-4.938-7.837-8.129-8.075-10.179-5.661-4.159-0.983
WPA (Winst Per Aandeel) -3.38-3.2-5.01-2.47-5.1-2.51-3.08-3.38-3.12-2-1.81-2.29-1.95-2.27-2.36-2.5-2.96-2.52-2.99-2.87-3.03-3.11-2.1-1.97-0.23
Verwaterde WPA -3.38-3.2-5.01-2.47-5.1-2.51-3.08-3.38-3.12-2-1.81-2.29-1.95-2.27-2.36-2.5-2.96-2.52-2.99-2.87-3.03-3.11-2.1-1.89-0.23
EBITDA -2.321-3.527-2.32-1.85-2.122-1.745-1.515-1.554-2.103-1.831-1.638-2.168-2.366-1.87-2.034-2.257-2.803-2.422-3.279-3.191-2.973-3.358-2.056-2.017-3.429
EBITDA ratio -464.2-62.982-50.435-205.556-212.2-218.125-168.333-129.5-420.6-67.815-68.25-58.595-42.25-3.703-4.687-5.452-5.443-4.412-7.978-8.397-7.662-10.728-5.411-4.347-14.347